Recent Quotes (30 days)

You have no recent quotes
chg | %

Pacgen Life Science Corp  

(Public, CVE:PBS)   Watch this stock  
Find more results for CVE:PGA
0.0150
0.0000 (0.00%)
Delayed:   9:38AM EST
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.09
Open     -
Vol. 0.00
Mkt cap 708,240.00
P/E     -
Div/yield     -
EPS     -
Shares 47.22M
Beta 0.79
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 53.78% 142.91%
Operating margin 50.56% 138.10%
EBITD margin - 138.34%
Return on average assets 24.27% 137.00%
Return on average equity 125.02% -
Employees 10 -
CDP Score - -

Address

Suite 1500, 701 West Georgia Street
VANCOUVER, BC V7Y 1C6
Canada
+1-604-4364388 (Phone)
+1-604-4364380 (Fax)

Website links

Description

Pacgen Life Science Corporation is Life Science Company. The Company is focused on the commercialization of biomedical product and services. The Company´┐Żs product includes Fit X1 Series, Electronic Pipettes, A+Pipette Controller. The Company reported positive results from its Phase IIb dose-ranging clinical trial for its lead product candidate, PAC-113, a anti-fungal drug. PAC-113 is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in saliva. This peptide alters the permeability of fungal cell membranes causing cell death. PAC-113 is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in saliva. This peptide alters the permeability of fungal cell membranes causing cell death.

Officers and directors

Chung-Yu Yu Wang Chairman of the Board, Interim President and Chief Executive Officer
Christina Yip Chief Financial Officer, Corporate Secretary
Ming Sun Liu Ph.D. Director
Jeng-Horng Her Independent Director
Min-Chih Hsuan Independent Director
Age: 60
Frederick Huang Independent Director
Telvin Ju Ph.D. Independent Director